Regenerative Medical Technology (RMTG) Receivables - Other (2021 - 2025)
Historic Receivables - Other for Regenerative Medical Technology (RMTG) over the last 5 years, with Q3 2025 value amounting to $8.2 million.
- Regenerative Medical Technology's Receivables - Other changed 0.0% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $8.2 million for FY2024, which is 0.0% changed from last year.
- As of Q3 2025, Regenerative Medical Technology's Receivables - Other stood at $8.2 million, which was down 0.0% from $8.2 million recorded in Q2 2025.
- Regenerative Medical Technology's Receivables - Other's 5-year high stood at $8.2 million during Q1 2022, with a 5-year trough of $17257.0 in Q4 2021.
- Its 5-year average for Receivables - Other is $6.9 million, with a median of $8.2 million in 2022.
- In the last 5 years, Regenerative Medical Technology's Receivables - Other surged by 4741694.96% in 2022 and then changed by 0.0% in 2023.
- Over the past 5 years, Regenerative Medical Technology's Receivables - Other (Quarter) stood at $17257.0 in 2021, then skyrocketed by 47416.95% to $8.2 million in 2022, then changed by 0.0% to $8.2 million in 2023, then changed by 0.0% to $8.2 million in 2024, then changed by 0.0% to $8.2 million in 2025.
- Its last three reported values are $8.2 million in Q3 2025, $8.2 million for Q2 2025, and $8.2 million during Q1 2025.